TAMOXIFEN - NEW MEMBRANE-MEDIATED MECHANISMS OF ACTION AND THERAPEUTIC ADVANCES

被引：117
作者：
WISEMAN, H [1 ]
机构：
[1] ROYAL FREE HOSP,SCH MED,DEPT BIOCHEM,LONDON NW3 2PF,ENGLAND
来源：
TRENDS IN PHARMACOLOGICAL SCIENCES | 1994年 / 15卷 / 03期
关键词：
D O I：
10.1016/0165-6147(94)90283-6
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Tamoxifen protects membranes and lipoprotein particles against oxidative damage. This antioxidant action is likely to contribute to the observed cardioprotective action of tamoxifen and supports the use of this compound in treating and even preventing breast cancer. Membrane-mediated mechanisms of tamoxifen action, through a putative modulation of membrane fluidity, are likely to play an important role in its anticancer action and its ability to reverse multidrug resistance, and could also lead to clinical uses as an anti-Candida and anti-viral agent. In this review, Helen Wiseman discusses the interaction of tamoxifen with membranes and lipoprotein particles, and considers the possible clinical implications.
引用
收藏
页码：83 / 89
页数：7
相关论文
共 45 条
[41]   TAMOXIFEN AND RELATED-COMPOUNDS DECREASE MEMBRANE FLUIDITY IN LIPOSOMES - MECHANISM FOR THE ANTIOXIDANT ACTION OF TAMOXIFEN AND RELEVANCE TO ITS ANTICANCER AND CARDIOPROTECTIVE ACTIONS [J].
WISEMAN, H ;
QUINN, P ;
HALLIWELL, B .
FEBS LETTERS, 1993, 330 (01) :53-56
[42]   MECHANISM OF INHIBITION OF LIPID-PEROXIDATION BY TAMOXIFEN AND 4-HYDROXYTAMOXIFEN INTRODUCED INTO LIPOSOMES - SIMILARITY TO CHOLESTEROL AND ERGOSTEROL [J].
WISEMAN, H ;
CANNON, M ;
ARNSTEIN, HRV ;
HALLIWELL, B .
FEBS LETTERS, 1990, 274 (1-2) :107-110
[43]  
WISEMAN H, IN PRESS METH ENZYMO
[44]  
WISEMAN H, IN PRESS BREAST CANC
[45]  
WISEMAN H, IN PRESS BIOCH PHARM
12345